On Jan 12, 2026, BMRA reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were BIOMERICA INC's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, BIOMERICA INC reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to BIOMERICA INC's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is BIOMERICA INC expected to report next?
The next earning report is scheduled for Apr 13, 2026.
What are the forecasts for BIOMERICA INC's next earnings report?
Based on --
analysts, BIOMERICA INC is expected to report EPS of -- and revenue of -- for Q3 2026.